Adamant Biomedical Investments’s IQVIA IQV Stock Holding History

Adamant Biomedical Investments’s Portfolio IQV Stock Details IQV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$589K	Buy	+10,000	New	+$571K	0.14%	89

Other funds holding IQV

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

3I Investments London Swie 5jd, United Kingdom $259M AUM 10.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Adamant Biomedical Investments's IQV Position: Q4 2014 in Review

Adamant Biomedical Investments opened a new position in IQVIA (IQV) in Q4 2014: 10,000 shares worth $589K. The stake represents 0.14% of the portfolio and ranks #89 among its holdings.

265 funds tracked by Wall St. Rank hold IQV as of Q4 2014.

Adamant Biomedical Investments held 10,000 shares of IQVIA worth $589K as of Q4 2014.
IQVIA was a new Adamant Biomedical Investments position in Q4 2014.
IQVIA made up 0.14% of Adamant Biomedical Investments's portfolio in Q4 2014, its #89 holding.
265 funds tracked by Wall St. Rank held IQVIA as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.